Pic.6. A cross-section of participants, during a news conference on Gilead profiteering and refusal to allow generic production of lifesaving medication for HIV/AIDS, Hepatitis and Meningitis, organised by AHF in collaboration with Civil Society Organisations in Abuja on Thursday (22/6/23). 02128/22/6/2023/Jimah Suleman/NANPic.5. From left: Executive Secretary, NINERELA+, Amber Itohan-Erinmwinhe; Director, Advocacy, Policy and Marketing, AIDS Healthcare Foundation (AHF) Africa Bureau, Oluwakemi Gbadamosi-Braimah and Advocacy Specialist, Network of People Living with HIV/AIDS in Nigeria, Mike Edeh, during a news conference on Gilead profiteering and refusal to allow generic production of lifesaving medication for HIV/AIDS, Hepatitis and Meningitis, organised by AHF in collaboration with Civil Society Organisations in Abuja on Thursday (22/6/23). 02127/22/6/2023/Jimah Suleman/NANPic.4. From left: National Deputy Coordinator, Association of Positive Youths living with HIV/AIDS in Nigeria, Kareem Samsudeen; Executive Secretary, NINERELA+, Amber Itohan-Erinmwinhe; Director, Advocacy, Policy and Marketing, AIDS Healthcare Foundation (AHF) Africa Bureau, Oluwakemi Gbadamosi-Braimah and Advocacy Specialist, Network of People living with HIV/AIDS in Nigeria, Mike Edeh, during a news conference on Gilead profiteering and refusal to allow generic production of lifesaving medication for HIV/AIDS, Hepatitis and Meningitis organised by AHF in collaboration with Civil Society Organisations in Abuja on Thursday (22/6/23). 02126/22/6/2023/Jimah Suleman/NAN
